
|Articles|February 18, 2016
INC Research Kicks Off Sites Initiative
The goal of the Catalyst program is to strengthen collaborations with clinical research sites worldwide through network and community approaches.
Advertisement
INC Research officially launched the company's Catalyst program, designed to strengthen collaborations with clinical research sites worldwide. Investigative sites that take part in the program will have the opportunity to participate in an increased volume of clinical studies, according to INC. Participation is by invitation only and the initial focus is on oncology and vaccine sites in the U.S. and the Asia-Pacific region.
The program includes two components-the Catalyst Site Network and the Catalyst Community.
Read the
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Quantifying the Net Financial Value of Deploying Risk-Based Quality Management
2
ACT Brief: RBQM Financial Value Quantified, Sponsor-Configurable AI Systems, and Basket Trials for Rare Pediatrics
3
PLPS Launches MyClinicalSuite™ to Deliver Faster Clinical Trial Label Turnarounds Without Compromising Quality, Compliance, or Patient Safety
4
ACT Brief: Enterprise Risk Management, Execution Architecture for AI, and Rare Pediatric Regulatory Support
5




